It should be hard to miss, but America’s biomedical innovators and industry — that is, private companies putting their own or investors’ or both’s private re...

March 16 marks the close of a public comment period for the latest commendable initiative by Russ Vought’s Office of Management and Budget. The relentless ex...

Trump administration innovation agency officials have issued a new joint policy statement affirming the right of certain crucial patents to meaningful enforc...

In policy and legal circles, judicial injunctions have gotten a bad reputation. Not totally without justification, with judicial activists wielding their equ...

On October 6-27, Pope Francis is hosting at the Vatican a Synod of Bishops from the Pan Amazon region. Ostensibly, the Synod’s purpose is to gather bishops, ...

A free economy is a terrible thing to waste. That and the high standard of living, the time- and labor-saving advances, the dynamic competition, innovation a...

You have to be concerned over the “inflationary penalty” proposed as a means of reducing drug prices in Medicare Part D. Well, you do if you care about prope...

The Senate Judiciary Committee is poised to fall down a slippery slope: the willingness to take someone else’s private property when those property rights ge...

The opioids epidemic is back in the news. U.S. Health and Human Services is widening the implementation of strategies that have significantly reduced opioid ...

Don’t look now, but we’re about to see a step toward common sense by the Environmental Protection Agency and the Army Corps of Engineers. Under the Trump adm...

Congress has received an open letter stating principles that should direct policymakers on intellectual property issues. More than 70 organizations, includin...

“Happy New Year!” means ’tis the season for new year’s resolutions. Time for expressing good intentions. Alas, many of those promises to ourselves may not la...